• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • Sponsored Placement
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Global mRNA Vaccines Market Report 2021-2027: COVID-19 Vaccine Segment is Projected to Record a -5.9% CAGR and Shrink to a Market Size of $22.2 Billion

Research and Markets Logo

News provided by

Research and Markets

Mar 10, 2021, 09:15 ET

Share this article

Share this article


DUBLIN, March 10, 2021 /PRNewswire/ -- The "mRNA Vaccines - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global mRNA Vaccines Market to Reach $30.5 Billion by 2027

Amid the COVID-19 crisis, the global market for mRNA Vaccines estimated at US$ 31.9 Billion in the year 2021, is projected to reach a size of US$ 30.5 Billion by 2027, displaying at a CAGR of -0.7% over the analysis period 2021-2027.

COVID-19 Vaccine, one of the segments analyzed in the report, is projected to record a -5.9% CAGR and shrink to a market size of approximately US$ 22.2 Billion by the end of the analysis period.

After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the cancer vaccine segment is projected to spiral at 166.7% CAGR for the next 6-year period.

The U.S. Market is Estimated at $14.7 Billion, While Asia-Pacific is Forecast to Grow at 12.8% CAGR

mRNA Vaccines market in the U.S. is estimated at US$ 14.7 Billion in the year 2021. Asia-Pacific (excluding China) is forecast to reach a projected market size of US$ 3.6 Billion by the year 2027 trailing a CAGR of 12.8% over the analysis period 2021 to 2027.

Among the other noteworthy geographic markets are China and Rest of World (includes Latin America, Middle East and Africa), each forecast to grow at 10% and 4.2% respectively over the 2021-2027 period.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Global Competitor Market Shares
  • mRNA Vaccines and Therapeutics Competitor Market Share Scenario Worldwide (in %): E
  • Global Competitor Market Shares by Segment
  • Standardization of Cancer Treatment (Type) Global Competitor Market Share Positioning for 2020 & 2027
  • Infection Disease Treatment (Type) Market Share Breakdown of Key Players: 2020 & 2027
  • Infection Prevention (Type) Competitor Revenue Share (in %): 2020 & 2027
  • Individualized Cancer Treatment (Type) Market Share Shift by Company: 2020 & 2027

2. FOCUS ON SELECT PLAYERS (Total 100 Featured)

  • Arcturus Therapeutics, Inc.
  • Argos Therapeutics, Inc.
  • BioNTech SE
  • CureVac AG
  • eTheRNA
  • ethris GmbH
  • GlaxoSmithKline PLC
  • Moderna Therapeutics Inc.
  • Pfizer Inc.
  • Sangamo Therapeutics Inc.
  • Translate Bio Inc.

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • World Current & Future Analysis for mRNA Vaccines by Geographic Region - Independent Analysis of Annual Sales in US$ Million for Years 2021 through 2027 and % CAGR
  • World 6-Year Perspective for mRNA Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Years 2021, 2021 & 2027
  • World Current & Future Analysis for Covid-19 Vaccine by Geographic Region - Independent Analysis of Annual Sales in US$ Million for Years 2021 through 2027 and % CAGR
  • World 6-Year Perspective for Covid-19 Vaccine by Geographic Region - Percentage Breakdown of Value Sales for Years 2021, 2021 & 2027
  • World Current & Future Analysis for Cancer Vaccine by Geographic Region - Independent Analysis of Annual Sales in US$ Million for Years 2021 through 2027 and % CAGR
  • World 6-Year Perspective for Cancer Vaccine by Geographic Region - Percentage Breakdown of Value Sales for Years 2021, 2021 & 2027
  • World Current & Future Analysis for Other Indications by Geographic Region - Independent Analysis of Annual Sales in US$ Million for Years 2021 through 2027 and % CAGR
  • World 6-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for Years 2021, 2021 & 2027
  • World Historic Review for mRNA Vaccines by Geographic Region - Independent Analysis of Annual Sales in US$ Million for Years 2021 through 2020 and % CAGR
  • World Historic Review for Covid-19 Vaccine by Geographic Region - Independent Analysis of Annual Sales in US$ Million for Years 2021 through 2020 and % CAGR
  • World Historic Review for Cancer Vaccine by Geographic Region - Independent Analysis of Annual Sales in US$ Million for Years 2021 through 2020 and % CAGR
  • World Historic Review for Other Indications by Geographic Region - Independent Analysis of Annual Sales in US$ Million for Years 2021 through 2020 and % CAGR

III. MARKET ANALYSIS

  • UNITED STATES
  • Market Facts & Figures
  • US mRNA Vaccines and Therapeutics Market Share (in %) by Company: 2020 & 2027
  • Standardization of Cancer Treatment (Type) Market Share Analysis (in %) of Leading Players in the US for 2020 & 2027
  • Infection Disease Treatment (Type) Competitor Revenue Share (in %) in the US: 2020 & 2027
  • Infection Prevention (Type) Market Share Breakdown (in %) of Major Players in the US: 2020 & 2027
  • Individualized Cancer Treatment (Type) Market in the US: Percentage Breakdown of Revenues by Company for 2020 & 2027
  • Market Analytics
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • Market Facts & Figures
  • European mRNA Vaccines and Therapeutics Market: Competitor Market Share Scenario (in %) for 2020 & 2027
  • Standardization of Cancer Treatment (Type) Market Share (in %) by Company in Europe: 2020 & 2027
  • Infection Disease Treatment (Type) Market Share (in %) of Major Players in Europe: 2020 & 2027
  • Infection Prevention (Type) Competitor Market Share Analysis (in %) in Europe: 2020 & 2027
  • Individualized Cancer Treatment (Type) Market in Europe: Competitor Revenue Share Shift (in %) for 2020 & 2027
  • Market Analytics
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • REST OF EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

COMPETITION

  • Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/tzig5i

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Modal title

Also from this source

Worldwide Mineral Wool Industry to 2030 - Increasing Construction ...

Worldwide Mineral Wool Industry to 2030 - Increasing Construction ...


Military Ethernet Switches Market Poised to Surpass $3.11 Billion ...

Military Ethernet Switches Market Poised to Surpass $3.11 Billion ...

Explore

More news releases in similar topics

  • Publishing & Information Services
  • Pharmaceuticals
  • Health Care & Hospitals
  • Medical Pharmaceuticals
  • Surveys, Polls and Research

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.